High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma

Medical Oncology

Volumn 30, Issue 1, 2013, Pages

  Lv, Yang ^a   Wang, Wei ^a   Jia, Wei Dong ^a   Sun, Qi Kai ^a   Li, Jian Sheng ^a   Ma, Jin Liang ^a   Liu, Wen Bin ^a   Zhou, Hang Cheng ^a   Ge, Yong Sheng ^a   Yu, Ji Hai ^a   Xia, Hong Hai ^a   Xu, Ge Liang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Periostin; Prognosis

Indexed keywords

CD34 ANTIGEN; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84871571354     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0385-7     Document Type: Article

References (25)

1. Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Fan ST, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg. 2011;253:745-58.
3. Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993; 294(Pt1):271-8.
4. Gillan L, et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002;62:5358-64.
5. Bao S, et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 2004;5:329-39.
6. Shao R, et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol. 2004;24:3992-4003.
7. Kudo Y, et al. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 2006;66:6928-35.
8. Siriwardena BS, et al. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer. 2006;95:1396-403.
9. Chang Y, et al. Differential expression of osteoblast-specific factor 2 and polymeric immunoglobulin receptor genes in nasopharyngeal carcinoma. Head Neck. 2005;27:873-82.
10. Fluge O, Bruland O, Akslen LA, Lillehaug JR, Varhaug JE. Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid. 2006;16:161-75.
11. Baril P, et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene. 2007;26:2082-94.
12. Erkan M, et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology. 2007;132:1447-64.
13. Ismail RS, et al. Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res. 2000;60:6744-9.
14. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462-503.
15. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
16. Kikuchi Y, et al. Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon. J Histochem Cytochem. 2008;56:753-64.
17. Tai IT, Dai M, Chen LB. Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis. 2005;26:908-15.
18. Kim CJ, et al. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int J Cancer. 2005;117:51-8.
19. Kim CJ, et al. Role of alternative splicing of periostin in human bladder carcinogenesis. Int J Oncol. 2008;32:161-9.
20. Kanno A, et al. Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells. Int J Cancer. 2008;122:2707-18.
21. Suzuki K, et al. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res. 1996;56:3004-9.
22. Riener MO, et al. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology. 2010;56:600-6.
23. Wang W, Ma JL, Jia WD, Xu GL. Periostin: a putative mediator involved in tumour resistance to anti-angiogenic therapy? Cell Biol Int. 2011;35:1085-8.
24. Li G, et al. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis. 2010;208:358-65.
25. Utispan K, et al. Periostin activates integrin alpha5beta1 through a PI3 K/AKTdependent pathway in invasion of cholangiocarcinoma. Int J Oncol. 2012;41:1110-8.